Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

STAAR Surgical Company - Common Stock (NQ:STAA)

26.90 -0.35 (-1.28%)
Streaming Delayed Price Updated: 12:15 PM EDT, Oct 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about STAAR Surgical Company - Common Stock

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Benzinga's Top Ratings Upgrades, Downgrades For April 8, 2022
Upgrades 
Via Benzinga
STAAR Surgical Announces First Implants of EVO Visian ICL in the U.S.
From STAAR Surgical Company
Via Business Wire
Stocks That Hit 52-Week Lows On Tuesday
Tuesday morning saw 454 companies set new 52-week lows. Interesting Facts About Today's 52-Week Lows: Unilever (NYSE:UL) was the largest firm by market cap to set a... 
Via Benzinga
50 Biggest Movers From Yesterday
Gainers Hycroft Mining Holding Corporation (NASDAQ: HYMC) shares gained 81.3% to close at $2.32 on Monday. Last week, AMC Entertainment Holdings purchased a major stake in... 
Via Benzinga
35 Stocks Moving In Monday's Mid-Day Session
Gainers Hycroft Mining Holding Corporation (NASDAQ: HYMC) jumped 57.1% to $1.96 following reports regarding potential future investments from AMC CEO, Adam Aron.... 
Via Benzinga
Why STAAR Surgical's Shares Are Gaining Today
The FDA approved STAAR Surgical Company's (NASDAQ: STAA) EVO/EVO+ Visian Implantable Collamer Lens to correct myopia and myopia with astigmatism. Myopia, also... 
Via Benzinga
Futures Reverse Overnight Losses As More Curves Invert, Yen Plummets To 7 Year Low
After initially sliding lower, US equity futures reversed and erased earlier declines, climbing 0.2% along with Nasdaq futures as Stoxx Europe 600 extends gains to 1.1%. 
Via Talk Markets
Staar Surgical Rockets After FDA Clears Its Implantable Lens For Nearsightedness
Staar Surgical won Food and Drug Administration clearance for its implantable nearsightedness lens on Monday, leading STAA stock to soar. 
Via Investor's Business Daily
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers OncoSec Medical (NASDAQ:ONCS) shares moved upwards by 27.1% to $1.5 during Monday's pre-market session. The company's market cap stands at $59.0 million.... 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Welcome back, trader! It's time to start off the week with an overview of the biggest pre-market stock movers for Monday! 
Via InvestorPlace
22 Stocks Moving in Monday's Pre-Market Session
Gainers Hycroft Mining Holding Corporation (NASDAQ: HYMC) rose 27.3% to $1.63 in pre-market trading. Last week, AMC Entertainment Holdings purchased a major stake in Hycroft Mining Holding. 
Via Benzinga
STAAR Surgical Announces U.S. FDA Approval of EVO Visian® Implantable Collamer® Lenses
From STAAR Surgical Company
Via Business Wire
BTIG Upgraded Staar Surgical Stock - Read Why
BTIG upgraded Implantable lenses-focused Staar Surgical Company (NASDAQ: STAA) to Buy from Neutral with a $98 price target. Analyst Ryan Zimmerman believes... 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 18, 2022
Upgrades For United Airlines Holdings Inc (NASDAQ:UAL), Exane BNP Paribas upgraded the previous rating of Underperform to Neutral. United Airlines Holdings earned $1.60 in... 
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
During Tuesday's session, 454 stocks hit new 52-week lows. Intriguing Points From Today's 52-Week Lows: Taiwan Semiconductor (NYSE:TSM) was the largest company by... 
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
On Monday, 671 companies achieved new lows for the year. Points of Interest From Today's 52-Week Lows: Alibaba Group Holding (NYSE:BABA) was the largest firm by... 
Via Benzinga
88 Biggest Movers From Yesterday
Gainers Cyren Ltd. (NASDAQ: CYRN) shares surged 118.9% to settle at $4.75 on Thursday. Cyren recently announced a $12 million private placement. Indonesia Energy Corporation... 
Via Benzinga
Staar Surgical: Q4 Earnings Insights
Staar Surgical (NASDAQ:STAA) reported its Q4 earnings results on Wednesday, February 23, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings... 
Via Benzinga
STAAR Surgical Reports Fourth Quarter and Full Year 2021 Results
From STAAR Surgical Company
Via Business Wire
STAAR Surgical to Report Fourth Quarter and Fiscal Year Results on February 23, 2022
From STAAR Surgical Company
Via Business Wire
STAAR Surgical Announces Preliminary Fourth Quarter and Full Year 2021 Results
From STAAR Surgical Company
Via Business Wire
Earnings Scheduled For February 23, 2022
Companies Reporting Before The Bell • Sapiens Intl Corp (NASDAQ:SPNS) is likely to report earnings for its fourth quarter. • Plymouth Industrial REIT (NYSE:PLYM)... 
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
During Friday's session, 445 companies made new 52-week lows. Noteable 52-Week Lows: Intuitive Surgical (NASDAQ:ISRG) is the largest company in terms of market cap to... 
Via Benzinga
STAAR Surgical Company (STAA) Q3 2021 Earnings Call Transcript
STAA earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
STAAR Surgical Reports Third Quarter Net Sales of $58.4 Million Up 24% Y/Y
From STAAR Surgical Company
Via Business Wire
STAAR Surgical to Report Third Quarter Results on November 3, 2021
From STAAR Surgical Company
Via Business Wire
Down More Than 18% in 3 Months, Is STAAR Surgical Still A Buy?
Its valuation might be a sticking point. 
Via The Motley Fool
Earnings Scheduled For November 3, 2021
Companies Reporting Before The Bell • R.R.Donnelley & Sons (NYSE:RRD) is likely to report quarterly earnings at $0.32 per share on revenue of $1.19 billion.... 
Via Benzinga
Penumbra Stock Registers A Healthy RS Rating
Penumbra shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 77 to 81. 
Via Investor's Business Daily
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.